HB 586 Maryland
See bill link to HB 586 to note IDSA's drastic changes
– 1 –
(House Bill 586)
AN ACT concerning Consumer Products Safety – Lead and Mercury Reduction Act
Statewide Advisory Commission on Immunizations – Influenza Vaccines – Study
FOR the purpose of prohibiting certain persons from administering vaccines that
contain more than a certain amount of mercury per dose; prohibiting the sale,
offer for sale, or distribution in the State of certain drugs that contain mercury;
prohibiting the sale, offer for sale, or distribution in the State of cosmetics that
contain lead or mercury; providing for a delayed effective date; and generally
relating to prohibitions against the administering of vaccines with specified
levels of mercury and the sale of cosmetics and specified drugs that contain
mercury requiring the Statewide Advisory Commission on Immunizations to
conduct a certain study; requiring the Commission to make a certain report to
certain committees of the General Assembly on or before a certain date; and
generally relating to the Statewide Advisory Commission on Immunizations and
a study on the influenza vaccine.
BY adding to
Article – Health – General
Section 18–405, 21–228, and 21–232
Annotated Code of Maryland
(2005 Replacement Volume and 2007 Supplement)
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF
MARYLAND, That: the Laws of Maryland read as follows:
Article – Health – General
A PERSON LAWFULLY ADMINISTERING A VACCINE MAY NOT ADMINISTER A
VACCINE TO AN INDIVIDUAL IF THE VACCINE CONTAINS MORE THAN 1.25
MICROGRAMS OF MERCURY PER 0.5 MILLILITER DOSE.
(A) THE PROVISIONS OF THIS SECTION DO NOT APPLY TO THE SALE,
OFFER FOR SALE, OR DISTRIBUTION OF A PRESCRIPTION DRUG.
Ch. 169 MARTIN O’MALLEY, Governor
– 2 –
(B) A PERSON MAY NOT SELL, OFFER FOR SALE, OR DISTRIBUTE IN THE
STATE A DRUG THAT CONTAINS MERCURY.
A PERSON MAY NOT SELL, OFFER FOR SALE, OR DISTRIBUTE IN THE
STATE A COSMETIC THAT CONTAINS LEAD OR MERCURY.
(a) The Statewide Advisory Commission on Immunizations shall:
(1) Study the current availability and anticipated future availability of
single–dose influenza vaccines for use in the State; and
(2) Identify the current and anticipated future cost differential
between single–dose and multi–dose influenza vaccines; and
(b) On or before December 1, 2008, the Commission shall report its findings,
in accordance with § 2–1246 of the State Government Article, to the Senate Education,
Health, and Environmental Affairs Committee, the Senate Finance Committee, and
the House Health and Government Operations Committee.
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
January 1, 2009 June 1, 2008.
Approved by the Governor, April 24, 2008.